DGX
$198.61
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, a...
Recent News
1 Healthcare Stock with Exciting Potential and 2 We Avoid
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 3.6% gain over the past six months, beating the S&P 500 by 2.3 percentage points.
Elanco Animal Health (ELAN) Surges 7.6%: Is This an Indication of Further Gains?
Elanco Animal Health (ELAN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
A Look At Quest Diagnostics (DGX) Valuation After Recent Share Price Softness
Event overview and recent stock performance Quest Diagnostics (DGX) has been drawing attention after recent share price moves, with the stock down 0.4% over the past day and 1.3% over the past week, while remaining positive over the past 3 months and over the past year. See our latest analysis for Quest Diagnostics. Short term share price weakness contrasts with firmer momentum over longer periods, with the recent 3 month share price return of 11.35% and 1 year total shareholder return of...
4 Outpatient Home Health Stocks Gaining Attention Amid Market Shifts
An aging population and rising AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, OPCH and ADUS stand to benefit.
Beat the Market the Zacks Way: IPG Photonics, Celanese, Costco in Focus
IPG Photonics has surged 43.1% since a Zacks Rank #1 upgrade, showcasing how the firm's stock-picking approach is beating a volatile market.